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SUMMARY.-In two separate experiments benzopyrene has been painted
regularly on the backs of mice at difference dose levels.
It has been shown that the incidence rate of both tumours and infiltrating
carcinomas can be taken as proportional to d2(t W)k where t is time from
first application, w and k are constants independent of dose, and d is the applied
dose.
IT has been suggested that when a constant repetitive dose of carcinogen is
applied to a target area the incidence rate of tumours with time is approximately
proportional to (t W)k- I where t is time under insult and w and k are constants
(Pike, 1966).
It has also been pointed out that this hypothesis could most easily be tested
by reference to animal experimentation, but that it was not easy to find details
ofexperiments that included sufficient numbers of animals for statistical evalua-
tion (Cook, Doll andFellingham, 1969).
Accepting thishypothesis, it still remains to beshownhowthetumourincidence
rate at any fixed time depends on the carcinogenic insultapplied. The multistage
model of the cancer process (Armitage and Doll, 1954) postulates that if the
carcinogen affects X rate-determining stages of the process, then increasing the
dose by a factor C will increase the tumour incidence rate by a factor Cm.
Two large separate experiments were carried out at the T.R.C. Laboratories,
Harrogate, and the Batelle Institute, Geneva, using benzopyrene applied at 4
different dose levels to the shaved backs of mice.. The data from these experi-
ments was used to investigate the above hv-potheses.
MATERIALS AND METHODS
Benzopyrene (B.P.)
For the experiment in Harrogate 3,4-benzo(a)pyrene was obtained from the
Koch-Light Laboratories, Colnbrook, England, whereas for that in Geneva it
was obtained from Fluka Limited, Buchs SG, Switzerland.
Mice and details of treatment
(1) For the Harrogate experiment female albino mice of a specific pathogen- free strain were obtained from the Pharmaceuticals Division, Imperial Chemical
Industries Ltd., at 4-6 weeks of age, a month before first treatment.P. N. LEE AND J. A. 05NEILL 760
The mice were ranclomly allocated into 4 treatment groups each containing
300 mice.
Group I received 6 /,tg. of B.P. per week
Group 2 received 12 #g. of B.P. per week
Group 3 received 24 #g. of B.P. per week
Group 4 received 48 #g. of B.P. per week
The groups were further subdivided into 4 painting regimes know-n as 2, 3S,
3F and 31. On regime 2 applications were made twice a week on Tuesday and
Friday, on 3S three times a week on Monday, Wednesday and Friday, on 3F
three times a week on Tuesday, Wednesday and Friday and on 31 every other
day. Each application was made by means of an automatic pipette in a uniform
volume of 0
- 3 ml of acetone spread over the whole shaved back of the mouse.
Full post-mortem examination was performed on all mice (except in cases
where autolysis was too advanced), which were found dead overnight, appeared
irrecoverably ill, or tumourbearing animals when the tumour appeared malignant
as judged by the apparent attachment of the tumour to deeper structures of
the back.
Histological preparations were examined of all skin tumours, an area of
painted skin, and any other organ which appeared macroscopically abnormal at
post-mortem examination.
Applications were continued until the death of the animal or until 70 weeks,
when the experiment was terminated and all surviving mice were killed.
Tumours were recorded by visual inspection. The week of tumour was taken
as the week it was first observed on the living mouse whether or not it later
regressed or became malignant.
The criterion of malignancy adopted for tumours in the treated area was
penetration of the muscle fibres of the panniculus carnosus and mice satisfying
this criterion were said to have aninfiltrating carcinoma. The week ofinfiltrating
carcinoma was taken as the week of death of the animal.
(2) For the Battelle experiment female albino mice of a specific pathogen-free
strain were obtained from the University of Zurich, at 6-8 weeks of age in 5
successive intakes at 32-day intervals and were kept for a month before first
painting.
In each intake the mice were randomly allocated into 4 treatment groups
each containing 40 mice.
Group I received I Itg. of B.P. every fourth day
Group 2 received 3 /tg. of B.P. every fourth day
Group 3 received 9 #g. of B.P. every fourth day
Group 4 received 27 Itg. of B.P. every fourth day.
Each application was made by means of an automatic pipette in a uniform
volume of 0
- 2 ml. acetone spread over the whole shaved back of the mouse.
Applications were continued until the death ofthe animal or until termination
of the experiment after 60 8-day periods. This period is used as the minimum
experimental time interval for recording of data.
The criterion for recording a tumour was the same as in Harrogate, but
infiltrating carcinomas were not separately defined.761 BENZOPYRENE SKIN PAINTING EXPERIMENTS
RESULTS
Some extra tumours and infiltrating carcinomas were recorded at the week
of final killing, in the first case because a special search was carried out just
before the mice were killed and in the second because microscopy revealed carci-
nomas which would otherwise not have been found till a later date. In order to
avoid bias these results were ignored and the experiment effectively considered
only up to the week before the animals were killed.
TABLE I.-Battelle Experiment. Numbers ofTumour Bearing Mice Recorded
up to 59 8-day Periods (40 Animals perSubgroup)
Dose level lAg./4 days
Intake 1 3 9 27 Total
I 0 1 15 37 53
2 1 5 21 38 65
3 I 1 20 36 58
4 0 2 16 37 55
5 0 2 13 38 53
Total 2 11 85 186 284
TABLEII.-Harrogate Experiment. Numbers of Tumour Bearing Mice
Recorded up to 69 Weeks (75 Animals perSubgroup)
Dose level lAg./week
Dosing regime 6 12 24 48 Total
2 2 13 28 61 104
3S 2 15 25 58 100
3F 5 11 26 52 94
31 3 7 34 50 94
Total 12 46 113 221 392
TABLEIII.-Harrogate Experiment. Numbers ofInfiltrating Carcinoma
Bearing Mice Recorded up to 69 Weeks (75 Animals perSubgroup)
Dose level pg,/week
IL
Dosing regime 6 12 24 48 Total
2 0 1 4 32 37
3S 0 1 8 27 36
3F 0 1 7 18 26
31 0 1 8 22 31
Total 0 4 27 99 130
The total numbers of tumour and infiltrating carcinoma-beari'ng mice thus
recorded at the end of the experiment are given in Tables I, 11 and III.
In the notation of Pike (1966) the probability of an animal, which does not
die from some other cause beforehand, getting a tumour by time t can be given by
O(t k, w, b) exp (- b(t -W)k)
which is a particular case of the Weibull distribution. w and k are independent of the carcinogenic insult which is measured by the parameter b. Armitage and
Doll (1954) give an interpretation of the physical meaning of these porameters. In order to analyse the results in this way maximum likelihood estimates ofP. N. LEE AND J. A. 0NEILL 762
a common w and k and a separate b for each treatment subgroup were computed.
A programme to calculate these parameters by an amended Newton-Raphson
technique was written by Peto and Lee (unpublished).
Tables IV, V and VI give the values of the parameters fitted for each sub-
group.
In order to test the goodness of fit of these Weibull distributions to the data,
the results for each subgroup were divided into 5 time periods. The last 4 are
TABLEIV.-Fitted Weibull Parametem to Data of Table 1.
Battelle-Tumour8
w 14 43; k = 2
-245; values of b x 106
Dose level pg./4 days
Intake 1 3 9 27
1 0 5-9 99-2 1383-1
2 5.5 27-7 179-3 1536-9
3 5-6 5-8 165-7 1688-1
4 0 11.1 106-8 725-0
5 0 11-3 81-6 737-1
TABLE V.-Fitted Weib'ull Parameters to Data of Table II.
Harrogate-Tumour8
w = 17 70; k 2
-954; values of b x 10 7
Dose level /ig./week
A
Dosing regime 6 12 24 48
2 4-0 25-5 64-8 322-8
3S 3-3 28-7 59-9 269-5
3F 8-5 21-7 66-4 191-6
31 4-9 13-1 76-0 186-8
TABLE VI.-Fitted Weibull Parametem to Data of Table III.
Harrogate-Infiltrating Carcinomas
w = 22
-86; k = 2
-436; values of b x 10 6
Dose level ug./week
A
Dosing regime 6 12 24 48
2 0 1-6 6-9 65-5
3S 0 1-6 15-6 65-9
3F 0 1-7 13-4 35-6
31 0 1-6 13-1 45-3
equal divisions of the last 32 weeks (or 8-day periods for the Battelle experiment)
and the first period is the remainder, the beginning of the experiment. For
each period the observed numbers of tumours or carcinomas 0 were compared
with the expected number E using the fitted values ofb, w and k given in Tables
IV-VI. Each subgroup was analysed in this way and then summed over intakes
or regimes to give the results displayed in Tables VII, VIII and IX. Also given
in these tables is a value of the chi-squared statistic testing overall goodness
of fit for the 5 time periods. The number E' in the tables are 'used at a later
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TABLF, VIL-Ted of Goodne,88 ofFit of the Parametm ofTables IV and XIII
to the Data ofTable I. Battelle-Tumour8
Dose level jAg./4 days Period
(I unit = 8 days) Tumours 3 9 27 Total
1-27 0 1 3 58 63
E 0-14 0-78 7-96 62-65 71-53
E" 0.09 0-84 7-99 61-74 70-66
28-35 0 I 1 18 78 98
E 0-25 1-48 14-35 60-66 76-74
E" 0-17 1-61 14-42 60-05 76-25
36-43 0 0 5 17 32 054
E 0-40 2-28 19-31 32-70 54-69
E., 0-27 2-45 19-41 33-16 55-29
44-51 0 0 1 28 11 40
E 0-56 3-03 22-17 19-33 45-09
E'f 0-37 3-27 22-27 19-73 45-64
52-59 0 0 3 19 7 29
E 0-66 3-43 21-21 10-66 35-96
E., 0-44 3-70 21-22 10-83 36-19
1-59 0 2 11 85 186 284
E 2 11 85 186 284
El 1-33 11-87 85-32 185-52 284-04
2for 5 periods, total dose levels =- 8
-84E. 9 IIE', 4 d.f.
TABLE VIII.-Te8t of Goodnew ofFit of the Parametm ofTables V and XIV
to the Data of Table II. Harrogate,-Tumour8
Dose level ug./week Period
in weeks Tumours 6 12 24 48 Total
1-37 0 0 4 14 43 61
E 0.91 3-78 11-16 38-72 54-57 E., 1-03 3-41 11-56 37-99 53-99
38-45 0 2 2 17 49 70
E 1-47 6-11 16-86 51-65 76-09 E' 1-66 5-54 17-40 50-85 75-45
46-53 0 1 13 17 61 92
E 2-39 9-53 25-47 59-81 97-20 El 2-69 8-67 26-44 58-67 96-47
54-61 0 5 11 39 45 100
E 3-33 12-85 31-02 45-36 92-56
E 3-74 11-71 32-10 45-66 93-21
62-69 0 4 16 26 23 69
E 3-92 13-74 28-50 25-45 71-61 El 4-35 12-45 29-52 26-55 72-87
1-69 0 12 46 113 221 392
E 12 46 113 221 392
E 13-47 41-78 117-02 219-72 391-99
x2 for 5 periods, total dose levels = 2
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In Table IX the chi-squared is significantly high (P < 0
- 01) which would
appear to show lack of fit to the data. However, examination of the actual
numbers ofinfiltrating carcinomas occurring in each experimental period showed
that there were 14 in week 57 and 7 in week 58 whereas there were none at all
in weeks 53-56 and only 5 in weeks 59-63. This suggests that in weeks 57 and
58 the investigation for suspected carcinoma resulting in having the animals
killed was carried out more thoroughly than in the other weeks. This would
scarcely affect the fitted values of w, k and b as the weeks of tumour would be in
error by 3 or 4 at most. In any case no plausible model could predict this sort
of result.
TABLEIX.-TeSt of Goodness ofFit of theParameter8of Table8 VI and XV
to the Data ofTable III. Harrogate-Infiltrating Carcinomas
Dose level lAg./week
Period f
in weeks Tumours 6 12 24 48 Total
1-37 0 0 1 7 11 19
E 0 0-31 2-24 9-77 12-32
E., 0.09 0-40 2-01 9-92 12-42
38-45 0 0 0 5 14 19
E 0 0-55 3-87 16-91 21-33
El, 0-15 0-73 3-48 17-13 21-49
46-53 0 0 0 6 18 24
E 0 0-85 5-95 24-45 31-25
E., 0-24 1-13 5-36 24-69 31-42
54-61 0 0 2 4 19 25
E 0 1-13 7-46 27-09 35-68
E 0-31 1-52 6-75 27-39 35-97
62-69 0 0 1 5 37 43
E 0 1.19 7-46 20-80 29-45
E., 0-35 1-59 6-62 21-29 29-85
1-69 0 0 4 27 99 130
E 0 4 27 99 130
El, 1-14 5.37 24-22 100-42 131-15
2 for 5 periods, total dose levels = 14-99E, 14
-67E-'9 4 d.f.
A further indication ofgoodness of fit can be illustrated from the relation
109e 109e 10ge b + k (2)
obtained from (1) by taking natural logarithms twice. 0 was estimated by the
actuarially simulated number of tumours with a zero mortality standard popula-
tion (Lee, 1970). Figures 1, 2 and 3 show the goodness of fit to the theoretical
straight line relationship between 10ge (t w) and 10ge 10ge PAI G)) at either
4-week or 4 8-day intervals of t as long as the number of tumours or carcinomas
recorded up to time t exceeds 2. For each point plus or minus one standard
error bars are plotted. A separate line has been drawn for each dose level in
which the total tumours or carcinomas exceeded 5 with data combined either
over regimes or intakes. It seems clear that the fit to the Weibull distribution is
very good indeed.765 BENZOPYRENE SKIN PAINTING EXPERIMENTS
lt is evident from inspection of Tables IV-VI and Fig. 1-3 that there is a
very clear relationship between log, b and dose. Assuming k and w are known
we can, using methods described in the appendix, compute values of 'Y 2 to test
for differences in regime or intake, linear effect of dose, residual effects of dose
and interaction between dose level and intake. It can be seen from Tables X,
XI and XII that the main significant factor is the linear effect of dose and the
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only other significant effect is a difference in intakes in the Gallaher Experiment. Thus the relationship
10ge bij
== u + ai + 0 (log dosej) (3)
(where u is the mean value of log, b, ai is the effect of the ith regime or intake, j is the dose level and 0 a constant) completely describes the data. The fitted values for this relationship are also given in Tables X-XII.
The fitted constant 0 describes the dose-response relationship. In all three
cases the value of 0 is around 2 which means that increasing the dose by a factor of C increases the incidence rate by a factor of C2, for b is in fact an incidence rate multiplying factor. The value of 2 is in fact just outside two standardP. '-\-. LEE A-ND J. A. (7).N-EILL
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TABLE X11.-Variation oflog b with Dose and Regime in Data of Table III.
Harrogate-Infiltrating Carcinomas
Effect
Regime
Dose linear
Dose residual
Dose x Regime
d.f. Chi-squared
3 4 26
1 146 69
1* 0
- 73
6 4 22
p
N.S.
<0-0001
N.S.
N.S.
Model: log bij
= U + ai + 0 (log dosej); U = 18
- 767; 0 = 2 304, S.E. 0 = 0
-239;
a,
= 0 104; a2
== 0 233; a3
= 0 257; a4
= 0 080.
* Only one degree of freedom as the 6 jug./week dose level was omitted because there were no
infiltrating carcinomas. Assum'ng a linear relation the expected number of infiltrating carcinomas
at this dose is approxii-nately equal to one, which does not, disprove the goodness of fit of the linear
model.
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deviations from the fitted value of 0 for Harrogate Tumour Data whereas it is
well inside it for both the other sets of data. It is certainly not possible for
any integral value of 0 but 2 to be consistent with the data so that if the multi-
stage model ofArmitage and Doll were true then benzopyrene affects two stages ofthe cancer process.
It remains to be shown that the fittedrelationshipssubject to the dose response relationship of equation (3) actually fit the data adequately; Tables XIII-XV
give the fitted values of b in a similar manner to Tables IV-VI. Goodness of fit tests are given in Tables VII-IX where E' is the expected number of tumours
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or carcinomas calculated in a similar manner to the E's previously described
(page 762) except that the b's are those of Tables XIII-XV rather than those
of Tables IV-VI.
TABLEXIII.-Fitted Weibull Parameters to Data of Table I, Assuming the
Linear Model Between log Incidence Rate and log Dose given in Table X.
Battelle-Tumours
w 14 43; k = 2
-245; values of b x 10 6
Dose level jug./4 days
A
Intake 1 3 9 27
1 1-4 13-3 125-3 1178-4
2 2-0 18-6 175-2 1648-2
3 1.9 18-1 169-8 1596-8
4 1-0 9-0 84-5 794-6
5 0.9 8-5 79-7 749-4
TABLEXIV.-Fitted Weibull Parameters to Data ofTable II, A88uming the
Linear Model Between log Incidence Rate and log Dose Given in Table XI.
Harrogate-Tumours
w = 17
-70; k = 2
-954; values of b x 10 7
Dose level iLg./week
A
Dosing regime 6 12 24 48
2 6-5 22-2 76-4 262-6
3S 5-8 22-0 68-6 236-0
3F 4-9 16-8 57-6 198-2
31 4-7 16-2 55-7 191-6
TABLEXV.-Fitted Weibull Parameters to Data of Table III, Assuming the,
Linear Model Between log Incidence Rate and log Dose Given in Table XII.
Harrogate-Infiltrating Carcinomas
w = 22 86; k = 2
-436; values of b x 106
Dose level lAg./week
A
Dosing regime 6 12 24 48
2 0.5 2-4 11.9 58-7
3S 0-6 2-7 13-5 66-8
3F 0-4 1-7 8-3 40-9
31 0-4 2-0 9.9 48-9
DISCUSSION
It is clear that the model postulating the incidence rate of tumours from
benzopyrene to be proportional both to (time- W)k and to (dose)
2 is a very
good fit to the data from our experiments. Similar analyses carried out in
Harrogate on 7 experiments in which tobacco smoke condensate was painted at
different dose levels showed a marked difference in the results. Here although
over the dose range tested the log incidence rate increased in proportion to log dose the incidence rate-dose relationship was certainly not a quadratic one.
Averayina the experiments the incidence rate was about proportional to (dose)1.5. Benzopyrene is well known to be present in tobacco smoke condensate inBENZOPYRENE SKIN PAINTING EXPERIMENTS 769
small quantities. However, the difference in dose response relationships means
that benzopyrene cannot by itself be the cause of smoke condensate careino-
genesis. In any case calculations have shown that the amount ofthis carcinogen
present in condensate is only sufficient to account for a small part-very approxi-
mately one-seventieth-of the carcinogenicity of stored condensate (T.R.C.,
1970).
From the Armitage and Doll (1954) multistage hypothesis it seems possible that the quadratic response for benzopyrene is simply due to the carcinogen affecting two stages of the cancer process and that the I
-5th power response for condensate may well be an approximation from a mixture of a number of
linear and quadratic carcinogenic responses. For, assumed that the carcinogens
are non-interacting and that the linear part contributes Ii to the incidence rate
and the quadratic part,2for agiven dose level d. Then at dose 2d the incidence
rate will be 2I, + 4,2 and at dose 4d it will be 4I, + 16,2. As a compound
carcinogen it will appear to be linear at very small doses and quadratic at very large doses but in the middle range, taking Il 21 successive doublings of
dose multiply the rates by factors of 3 and 3-33. This sort of difference would
be indistinguishable in a condensate experiment especially when one considers
that for large doses, doubling the dose may well not double the effective dose
due to piling up on the mouse's back.
In order to test dose-response relationships from multistage models further
one would have to carry out experiments in which combinations of carcinogens at a wide range ofdose levels are applied.
We thank Dr. R. F. Davies and his staff in Harrogate and Dr. W. Surber and
Dr. A. Cerioli ofthe Battelle Institute, Geneva, for carrying out the experimental work.
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STATISTICAL APPENDIX
It can be shown (Pike, 1966) that the log fikehhood function L from a Weibull
distribution for r groups with known common k and w and unknown b == bi (i
=: I . . . r) is given by
r
L == E si log,, bi E bifi (4) i==1 i=1
where 8i is the number of tumours in the ith group andfi is equal to
E (X W)k
X>W
in the ith group where x for each animal is either its time of first tumour or its time of tumourless death.P. N. LEE AND J. A. 0)NEILL 770
Now consider anexperiment in which each combination of u = 1, 2 ... a treatments
and v 1, 2 ... b dose levels 1, are tested with8,,, and measured for each ofthe ab
combinations.
We can test the foRowing hypotheses.
(1) No effect of treatment or dose
10ge buv
= u
(2) No effect of dose
10ge buv
= u + gu
(3) No effect of treatment
10ge buv
= u + hv
(4) No treatment dose interaction
10ge buv
= u + gu + hv
(5) All groups different
10ge buv
= u + cuv
(6) No non-hnear effect of dose or dose treatment interaction
10ge buv
= u + gu + 0 (10ge 10
In each model by substituting for log buv in equation (4) and maximizing with respect
to the different parameters we attain six different log hkehhood maxima which we
shall caR Li through to L. respectively. L,, L2, L3and L5 can be expressed explicitly
in terms of the 8uv and the fuv but L4 and L. require an iterative procedure. Full
mathematical details are toolong to be given here but are available on request.
Using the Likehhood-Ratio Test we can set up a pseudo-analysis of variance table
in the style of Rao (1952) with chi-squareds replacing mean squares. It is laid out as
follows.
Variation D.F. 2
Dose (ignoringtreatment) b I - 2(L, L3)
Treatment a I - 2(L3 L4)
Treatment (ignoring dose) a I - 2(L, L2)
Dose b I - 2(L2- L4)
Dose Line'ar I - 2(L2 L6)
Dose Residual b 2 - 2(L6 L4)
Dose x Treatment (a 1)(b 1) - 2(L4 L5)